Back to ALL Research Publications
PUBLICATION_
PUBLICATION_
PUBLICATION_
PUBLICATION_
Research Category: ,
The clinical progression and wound healing rate of dehisced perineal tears healing by secondary intention: A prospective observational study
Related Publications
Related Material
PUBLICATION_ Diagnosis and treatment of the invasive extension of bacteria (cellulitis) from chronic wounds utilizing point-of-care fluorescence imaging
PUBLICATION_ Use of a bacterial fluorescence imaging system to target wound debridement and accelerate healing: a pilot study
PUBLICATION_ Point-of-care fluorescence imaging predicts the presence of pathogenic bacteria in wounds: a clinical study
PUBLICATION_ Utility of MolecuLight i:X for managing bacterial burden in pediatric burns
MolecuLight Headquarters
425 University Avenue Suite 700 Toronto, ON M5G 1T6 Canada
US Address MolecuLight Corp. 2403 Sidney Street, Suite 286 Pittsburgh, PA 15203
T. 1-877-818-4360
North American Toll Free:
1-877-818-4360
F.+1 647-362-4730
E: info@moleculight.com
©2026
The MolecuLight® i:X and MolecuLightDX™ Imaging Devices are approved by Health Canada for sale in Canada and has CE marking for sale in the European Union.
The MolecuLight™ i:X and DX Imaging Devices have received FDA clearance.








